US Patent Application No: 2001/0036,478

Core formulation

Stats

Nov 1, 2001
Publication date
Feb 15, 2001
filing date
09/783,810
serial no
Granted
status

ALSO PUBLISHED AS: 6461639

Importance

Loading Importance Indicators... loading....

Abstract

This invention relates to a controlled-release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.

Loading the Abstract Image... loading....

First Claim

loading....

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent Owner	Address	Total Patents
AEROPHARM TECHNOLOGY INCORPORATED	WESTON, FL	29
KOS LIFE SCIENCES, INC.	WESTON, FL	60

International Classification(s)

A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....

[Classification Symbol]

[Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Adjei, Akwete L	-	7	16
Cutie, Anthony J	-	3	5
Zhu, Yaping	-	10	18

Patent Citation Ranking

Forward Cites

Patent Info	(Count)	# Cites	Year
DEPOMED, INC. (1)
6,682,759 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs		46	2002

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	May 1, 2013

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00